Conflict of Interest Waiver Details For Cmte. Members Should Be Public – BMS
This article was originally published in The Tan Sheet
Executive Summary
FDA advisory committee members granted conflict of interest waivers should be required to disclose the companies to which they have financial ties, Bristol-Myers Squibb maintains in comments to FDA